Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Small-molecule inhibition of HIV-1 Vif.

Nathans R, Cao H, Sharova N, Ali A, Sharkey M, Stranska R, Stevenson M, Rana TM.

Nat Biotechnol. 2008 Oct;26(10):1187-92. doi: 10.1038/nbt.1496. Epub 2008 Sep 21.

2.

HIV-1 Vif, APOBEC, and intrinsic immunity.

Goila-Gaur R, Strebel K.

Retrovirology. 2008 Jun 24;5:51. doi: 10.1186/1742-4690-5-51. Review.

3.

Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.

Romani B, Engelbrecht S, Glashoff RH.

Arch Virol. 2009;154(10):1579-88. doi: 10.1007/s00705-009-0481-y. Epub 2009 Aug 12. Review.

PMID:
19669862
4.

[Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].

Fan B, Cen S, Jiang JD.

Yao Xue Xue Bao. 2008 Jul;43(7):678-82. Review. Chinese.

PMID:
18819469
5.

Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.

Henriet S, Mercenne G, Bernacchi S, Paillart JC, Marquet R.

Microbiol Mol Biol Rev. 2009 Jun;73(2):211-32. doi: 10.1128/MMBR.00040-08. Review.

6.

Apobec3G-Based Strategies to Defeat HIV Infection.

Ran X, Ao Z, Yao X.

Curr HIV Res. 2016;14(3):217-24. Review.

PMID:
26957196
7.

[Research methods of anti-HIV-1 inhibitors targeting at Vif-APOBEC3G axis].

Qiao X, Zhang W, Li Z, Zeng Y.

Zhongguo Zhong Yao Za Zhi. 2011 Mar;36(6):806-9. Review. Chinese.

PMID:
21710755
8.

APOBEC3G: an intracellular centurion.

Chiu YL, Greene WC.

Philos Trans R Soc Lond B Biol Sci. 2009 Mar 12;364(1517):689-703. doi: 10.1098/rstb.2008.0193. Review.

9.

APOBEC proteins and intrinsic resistance to HIV-1 infection.

Malim MH.

Philos Trans R Soc Lond B Biol Sci. 2009 Mar 12;364(1517):675-87. doi: 10.1098/rstb.2008.0185. Review.

10.

Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.

Smith JL, Bu W, Burdick RC, Pathak VK.

Trends Pharmacol Sci. 2009 Dec;30(12):638-46. doi: 10.1016/j.tips.2009.09.006. Review.

11.

Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Desimmie BA, Delviks-Frankenberrry KA, Burdick RC, Qi D, Izumi T, Pathak VK.

J Mol Biol. 2014 Mar 20;426(6):1220-45. doi: 10.1016/j.jmb.2013.10.033. Epub 2013 Nov 2. Review.

12.

Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes.

Grant M, Larijani M.

AIDS Res Ther. 2017 Sep 12;14(1):44. doi: 10.1186/s12981-017-0173-8. Review.

13.

A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent Degradation.

Bennett RP, Salter JD, Smith HC.

Trends Mol Med. 2018 May;24(5):507-520. doi: 10.1016/j.molmed.2018.03.004. Epub 2018 Mar 30. Review.

PMID:
29609878

Supplemental Content

Support Center